{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:55:00Z","timestamp":1769597700769,"version":"3.49.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1111\/j.1753-4887.2006.tb00184.x","type":"journal-article","created":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T22:14:10Z","timestamp":1227824050000},"page":"509-517","source":"Crossref","is-referenced-by-count":30,"title":["Menatetrenone (Vitamin K<sub>2<\/sub>) and Bone Quality in the Treatment of Postmenopausal Osteoporosis"],"prefix":"10.1093","volume":"64","author":[{"given":"Jun","family":"Iwamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Hip Intervention Program Study Group. Effect of risedro-nate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB3","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and non-vertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteo-poros Int"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB5","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB6","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB7","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB9","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of non-vertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study","volume":"90","author":"Reginster","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE). Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00198-004-1602-9","article-title":"Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study","volume":"15","author":"Delmas","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","article-title":"Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs","volume":"112","author":"Cummings","year":"2002","journal-title":"Am J Med"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","article-title":"Changes in bone density and turnover explain the reductions in incidence of non-vertebral fractures that occur during treatment with antiresorptive agents","volume":"87","author":"Hochberg","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1359\/jbmr.2000.15.3.515","article-title":"Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis","volume":"15","author":"Shiraki","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.amjmed.2004.05.019","article-title":"Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Study","volume":"117","author":"Ishida","year":"2004","journal-title":"Am J Med"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s007760100002","article-title":"Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate","volume":"6","author":"Iwamoto","year":"2001","journal-title":"J Orthop Sci"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4065\/80.3.379","article-title":"The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy","volume":"80","author":"Epstein","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00198-004-1725-z","article-title":"Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women","volume":"16","author":"Papapoulos","year":"2005","journal-title":"Osteoporos Int"},{"issue":"suppl 1","key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB20","first-page":"S397","article-title":"Hip and nonspine fracture risk reductions differ among antiresorptive agents. Evidence from randomized controlled trails","volume":"20","author":"Liberman","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1185\/030079904125003269","article-title":"Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis","volume":"20","author":"Wehren","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Alendronate Phase III Osteoporosis Treatment Study Group. Alendronate Phase III Osteoporosis Treatment Study Group. Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis","volume":"75","author":"Mellstrom","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB24","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1359\/JBMR.050509","article-title":"Continuing Outcomes Relevant to Evista (CORE) Investigators. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study","volume":"20","author":"Siris","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB25","first-page":"1249","article-title":"Clinical effect of menatetrenone on osteoporosis [In Japanese]","volume":"41","author":"Orimo","year":"1992","journal-title":"J New Remedies Clinics"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB26","first-page":"86","volume":"921","author":"The WHO Scientific Group: Prevention and management of osteoporosis","year":"2003","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB27","doi-asserted-by":"crossref","first-page":"43919","DOI":"10.1074\/jbc.M303136200","article-title":"Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR","volume":"278","author":"Tabb","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB28","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1152\/physrev.1989.69.3.990","article-title":"Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone","volume":"69","author":"Hauschka","year":"1989","journal-title":"Physiol Rev"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1359\/jbmr.1997.12.3.431","article-title":"Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro","volume":"12","author":"Koshihara","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(95)90227-9","volume":"345","author":"Shearer","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.nu.15.070195.000245","article-title":"Role of vitamin K in bone metabolism","volume":"15","author":"Vermeer","year":"1995","journal-title":"Annu Rev Nutr"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB32","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/ajcn\/71.5.1201","article-title":"Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women","volume":"71","author":"Booth","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0899-9007(00)00554-2","article-title":"Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hipfracture risk","volume":"17","author":"Kaneki","year":"2001","journal-title":"Nutrition"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB34","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1172\/JCI116387","article-title":"Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women","volume":"91","author":"Szulc","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/8756-3282(96)00037-3","article-title":"Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study","volume":"18","author":"Szulc","year":"1996","journal-title":"Bone"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB36","first-page":"719","article-title":"Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study","volume":"82","author":"Vergnaud","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB37","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1359\/jbmr.2000.15.12.2473","article-title":"Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin","volume":"15","author":"Luukinen","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ajcn\/69.1.74","article-title":"Vitamin K intake and hip fractures in women: a prospective study","volume":"69","author":"Feskanich","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB39","first-page":"45","article-title":"Clinical evaluation of Ea-0167 (menatetrenone) in the treatment of osteoporosis [In Japanese]","volume":"20","author":"Orimo","year":"1992","journal-title":"Clin Eval."},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s007760070003","article-title":"Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis","volume":"5","author":"Iwamoto","year":"2000","journal-title":"J Orthop Sci"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1507\/endocrj.49.363","article-title":"Time-dependent effects of vitamin K2 (menatetrenone) on bone metabolism in postmenopausal women","volume":"49","author":"Ozuru","year":"2002","journal-title":"Endocr J"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0378-5122(01)00275-4","article-title":"Effect of continuous combined therapy with vitamin K2 and vitamin D3 on bone mineral density and coagulofibrinolysis function in postmenopausal women","volume":"41","author":"Ushiroyama","year":"2002","journal-title":"Maturitas"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00223-001-2090-y","article-title":"A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis","volume":"71","author":"Shiraishi","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB44","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1359\/jbmr.2000.15.9.1810","article-title":"Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats","volume":"15","author":"Mawatari","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3349\/ymj.2003.44.5.751","article-title":"Combined treatment with vitamin K2 and bisphosphonate in post menopausal women with osteoporosis","volume":"44","author":"Iwamoto","year":"2003","journal-title":"Yonsei Med J"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB46","first-page":"51","article-title":"Bone mass, microstructure, and quality related with bone strength. The effects of antiresorp-tive agents [In Japanese]","volume":"12","author":"Ito","year":"2000","journal-title":"J Jpn Soc Bone Mor-phom"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00223-004-0277-8","article-title":"Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats","volume":"77","author":"Iwamoto","year":"2005","journal-title":"Calcif Tissue Int"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB48","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.bone.2004.05.012","article-title":"Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet","volume":"35","author":"Kobayashi","year":"2004","journal-title":"Bone"},{"key":"10.1111\/j.1753-4887.2006.tb00184.x-BIB49","first-page":"1147","article-title":"Vitamin K2 and bone quality","volume":"15","author":"Kobayashi","year":"2005","journal-title":"Clinical calcium [In Japanese]"}],"updated-by":[{"DOI":"10.1093\/nutrit\/nuaa026","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"record-id":"23413"}],"container-title":["Nutrition Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/64\/12\/509\/5388858\/nutritionreviews64-0509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T23:46:40Z","timestamp":1550274400000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-lookup\/doi\/10.1111\/j.1753-4887.2006.tb00184.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1753-4887.2006.tb00184.x","relation":{},"ISSN":["0029-6643","1753-4887"],"issn-type":[{"value":"0029-6643","type":"print"},{"value":"1753-4887","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}